166 related articles for article (PubMed ID: 34132929)
1. Surgical margin clearance and extended chemotherapy defines survival for synchronous oligometastatic liver lesions of the ductal adenocarcinoma of the pancreas.
Safi SA; Fluegen G; Rehders A; Haeberle L; Fung S; Keitel V; Krieg A; Knoefel WT; Lehwald-Tywuschik N
Int J Clin Oncol; 2021 Oct; 26(10):1911-1921. PubMed ID: 34132929
[TBL] [Abstract][Full Text] [Related]
2. Patients with hepatic oligometastatic pancreatic body/tail ductal adenocarcinoma may benefit from synchronous resection.
Yang J; Zhang J; Lui W; Huo Y; Fu X; Yang M; Hua R; Wang L; Sun Y
HPB (Oxford); 2020 Jan; 22(1):91-101. PubMed ID: 31262486
[TBL] [Abstract][Full Text] [Related]
3. Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysis.
Tachezy M; Gebauer F; Janot M; Uhl W; Zerbi A; Montorsi M; Perinel J; Adham M; Dervenis C; Agalianos C; Malleo G; Maggino L; Stein A; Izbicki JR; Bockhorn M
Surgery; 2016 Jul; 160(1):136-144. PubMed ID: 27048934
[TBL] [Abstract][Full Text] [Related]
4. Resection of pancreatic ductal adenocarcinoma with synchronous distant metastasis: is it worthwhile?
Buc E; Orry D; Antomarchi O; Gagnière J; Da Ines D; Pezet D
World J Surg Oncol; 2014 Nov; 12():347. PubMed ID: 25407113
[TBL] [Abstract][Full Text] [Related]
5. Impact of Margin Status on Survival in Patients with Pancreatic Ductal Adenocarcinoma Receiving Neoadjuvant Chemotherapy.
Schmocker RK; Delitto D; Wright MJ; Ding D; Cameron JL; Lafaro KJ; Burns WR; Wolfgang CL; Burkhart RA; He J
J Am Coll Surg; 2021 Apr; 232(4):405-413. PubMed ID: 33338577
[TBL] [Abstract][Full Text] [Related]
6. Surgery after FOLFIRINOX treatment for locally advanced and borderline resectable pancreatic cancer: increase in tumour attenuation on CT correlates with R0 resection.
Marchegiani G; Todaro V; Boninsegna E; Negrelli R; Sureka B; Bonamini D; Salvia R; Manfredi R; Pozzi Mucelli R; Bassi C
Eur Radiol; 2018 Oct; 28(10):4265-4273. PubMed ID: 29679211
[TBL] [Abstract][Full Text] [Related]
7. Survival Benefit of Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma Who Underwent Surgery Following Neoadjuvant FOLFIRINOX.
Lee SH; Hwang DW; Yoo C; Kim KP; Kang S; Jeong JH; Oh D; Song TJ; Lee SS; Park DH; Seo DW; Park JH; Song KB; Lee JH; Lee W; Park Y; Kwak BJ; Chang HM; Ryoo BY; Kim SC
Cancer Res Treat; 2023 Jul; 55(3):956-968. PubMed ID: 36915253
[TBL] [Abstract][Full Text] [Related]
8. Contemporary Reappraisal of Intraoperative Neck Margin Assessment During Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Review.
Datta J; Willobee BA; Ryon EL; Shah MM; Drebin JA; Kooby DA; Merchant NB
JAMA Surg; 2021 May; 156(5):489-495. PubMed ID: 33533898
[TBL] [Abstract][Full Text] [Related]
9. Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery?
Frigerio I; Regi P; Giardino A; Scopelliti F; Girelli R; Bassi C; Gobbo S; Martini PT; Capelli P; D'Onofrio M; Malleo G; Maggino L; Viviani E; Butturini G
Ann Surg Oncol; 2017 Aug; 24(8):2397-2403. PubMed ID: 28516291
[TBL] [Abstract][Full Text] [Related]
10. Mesopancreatic excision for pancreatic ductal adenocarcinoma improves local disease control and survival.
Safi SA; Haeberle L; Fluegen G; Lehwald-Tywuschik N; Krieg A; Keitel V; Luedde T; Esposito I; Rehders A; Knoefel WT
Pancreatology; 2021 Jun; 21(4):787-795. PubMed ID: 33775563
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of Resection Margin Involvement After Pancreaticoduodenectomy for Ductal Adenocarcinoma: Updates From a French Prospective Multicenter Study.
Delpero JR; Jeune F; Bachellier P; Regenet N; Le Treut YP; Paye F; Carrere N; Sauvanet A; Adham M; Autret A; Poizat F; Turrini O; Boher JM
Ann Surg; 2017 Nov; 266(5):787-796. PubMed ID: 28953554
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Impact of Resection Margin Status in Distal Pancreatectomy for Ductal Adenocarcinoma.
Sahakyan MA; Verbeke CS; Tholfsen T; Ignjatovic D; Kleive D; Buanes T; Lassen K; Røsok BI; Labori KJ; Edwin B
Ann Surg Oncol; 2022 Jan; 29(1):366-375. PubMed ID: 34296358
[TBL] [Abstract][Full Text] [Related]
13. Prospective assessment of resection margin status following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma after standardisation of margin definitions.
Pine JK; Haugk B; Robinson SM; Darne A; Wilson C; Sen G; French JJ; White SA; Manas DM; Charnley RM
Pancreatology; 2020 Apr; 20(3):537-544. PubMed ID: 31996296
[TBL] [Abstract][Full Text] [Related]
14. Defining distal splenopancreatectomy by the mesopancreas.
Safi SA; Alexander A; Neuhuber W; Haeberle L; Rehders A; Luedde T; Esposito I; Fluegen G; Knoefel WT
Langenbecks Arch Surg; 2024 Apr; 409(1):127. PubMed ID: 38625602
[TBL] [Abstract][Full Text] [Related]
15. Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability.
Shi HJ; Jin C; Fu DL
World J Gastroenterol; 2016 Dec; 22(45):10024-10037. PubMed ID: 28018110
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection?
Konstantinidis IT; Warshaw AL; Allen JN; Blaszkowsky LS; Castillo CF; Deshpande V; Hong TS; Kwak EL; Lauwers GY; Ryan DP; Wargo JA; Lillemoe KD; Ferrone CR
Ann Surg; 2013 Apr; 257(4):731-6. PubMed ID: 22968073
[TBL] [Abstract][Full Text] [Related]
17. Validation of at least 1 mm as cut-off for resection margins for pancreatic adenocarcinoma of the body and tail.
Hank T; Hinz U; Tarantino I; Kaiser J; Niesen W; Bergmann F; Hackert T; Büchler MW; Strobel O
Br J Surg; 2018 Aug; 105(9):1171-1181. PubMed ID: 29738626
[TBL] [Abstract][Full Text] [Related]
18. Effect of resection margin status on recurrence pattern and survival in distal pancreatectomy for left-sided pancreatic ductal adenocarcinoma.
Kwon J; Lee SR; Park SY; Lee JH; Song KB; Hwang DW; Shin JH; Kim SC
J Hepatobiliary Pancreat Sci; 2023 May; 30(5):633-643. PubMed ID: 36380718
[TBL] [Abstract][Full Text] [Related]
19. Impact of resection margin status on recurrence and survival in pancreatic cancer surgery.
Tummers WS; Groen JV; Sibinga Mulder BG; Farina-Sarasqueta A; Morreau J; Putter H; van de Velde CJ; Vahrmeijer AL; Bonsing BA; Mieog JS; Swijnenburg RJ
Br J Surg; 2019 Jul; 106(8):1055-1065. PubMed ID: 30883699
[TBL] [Abstract][Full Text] [Related]
20. Predictive factors for long-term survival after surgery for pancreatic ductal adenocarcinoma: Making a case for standardized reporting of the resection margin using certified cancer center data.
Weyhe D; Obonyo D; Uslar VN; Stricker I; Tannapfel A
PLoS One; 2021; 16(3):e0248633. PubMed ID: 33735191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
